Sales decline 14.64% to Rs 4.14 crore
Net profit of Beryl Drugs rose 100.00% to Rs 0.20 crore in the quarter ended June 2018 as against Rs 0.10 crore during the previous quarter ended June 2017. Sales declined 14.64% to Rs 4.14 crore in the quarter ended June 2018 as against Rs 4.85 crore during the previous quarter ended June 2017. ParticularsQuarter EndedJun. 2018Jun. 2017% Var.Sales4.144.85 -15 OPM %9.425.57 -PBDT0.350.23 52 PBT0.250.13 92 NP0.200.10 100Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
